Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Clofarabine in Previously Treated MDS
NCT00531232Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2007
- Primary completion
- May 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), sponsored by Sanofi. Started May 2007; status: completed.
02
Drugs
clofarabine
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00531232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531232.